Bos EM - Search Results

1

Kidney grafts from brain dead donors: Inferior quality or opportunity for improvement?

Bos EM, Leuvenink HG, van Goor H, Ploeg RJ. Bos EM, et al. Kidney Int. 2007 Oct;72(7):797-805. doi: 10.1038/sj.ki.5002400. Epub 2007 Jul 25. Kidney Int. 2007. PMID: 17653138 Free article. Review.

2

Renal expression of heat shock proteins after brain death induction in rats.

Bos EM, Schuurs TA, Kraan M, Ottens PJ, van den Eijnden MM, Leuvenink HG, Kampinga HH, van Goor H, Ploeg RJ. Bos EM, et al. Transplant Proc. 2005 Jan-Feb;37(1):359-60. doi: 10.1016/j.transproceed.2004.12.236. Transplant Proc. 2005. PMID: 15808643

3

COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.

van Eijk LE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos EM, Kolundzic N, Abdulle AE, van der Voort PH, Olde Rikkert MG, van der Hoeven JG, den Dunnen WF, Hillebrands JL, van Goor H. van Eijk LE, et al. Among authors: bos em. J Pathol. 2021 Jul;254(4):307-331. doi: 10.1002/path.5642. Epub 2021 Mar 25. J Pathol. 2021. PMID: 33586189 Free PMC article. Review.

4

Fighting Oxidative Stress with Sulfur: Hydrogen Sulfide in the Renal and Cardiovascular Systems.

Scammahorn JJ, Nguyen ITN, Bos EM, Van Goor H, Joles JA. Scammahorn JJ, et al. Among authors: bos em. Antioxidants (Basel). 2021 Mar 2;10(3):373. doi: 10.3390/antiox10030373. Antioxidants (Basel). 2021. PMID: 33801446 Free PMC article. Review.

5

Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia.

Bos EM, van Goor H, Joles JA, Whiteman M, Leuvenink HG. Bos EM, et al. Br J Pharmacol. 2015 Mar;172(6):1479-93. doi: 10.1111/bph.12869. Br J Pharmacol. 2015. PMID: 25091411 Free PMC article. Review.

6

Overexpression of Cystathionine γ-Lyase Suppresses Detrimental Effects of Spinocerebellar Ataxia Type 3.

Snijder PM, Baratashvili M, Grzeschik NA, Leuvenink HGD, Kuijpers L, Huitema S, Schaap O, Giepmans BNG, Kuipers J, Miljkovic JL, Mitrovic A, Bos EM, Szabó C, Kampinga HH, Dijkers PF, Bos EM, Szabó C, Kampinga HH, Dijkers PF, Dunnen WFAD, Filipovic MR, Goor HV, Sibon OCM. Snijder PM, et al. Among authors: bos em. Mol Med. 2016 Jan;21(1):758-768. doi: 10.2119/molmed.2015.00221. Epub 2015 Oct 13. Mol Med. 2016. PMID: 26467707 Free PMC article.

7

Hydrogen sulfide producing enzymes in pregnancy and preeclampsia.

Holwerda KM, Bos EM, Rajakumar A, Ris-Stalpers C, van Pampus MG, Timmer A, Erwich JJ, Faas MM, van Goor H, Lely AT. Holwerda KM, et al. Among authors: bos em. Placenta. 2012 Jun;33(6):518-21. doi: 10.1016/j.placenta.2012.02.014. Epub 2012 Mar 3. Placenta. 2012. PMID: 22391326 Free article.

8

Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Módis K, Bos EM, Calzia E, van Goor H, Coletta C, Papapetropoulos A, Hellmich MR, Radermacher P, Bouillaud F, Szabo C. Módis K, et al. Among authors: bos em. Br J Pharmacol. 2014 Apr;171(8):2123-46. doi: 10.1111/bph.12368. Br J Pharmacol. 2014. PMID: 23991749 Free PMC article. Review.

9

The Options for Neuraxial Drug Administration.

Hermanns H, Bos EME, van Zuylen ML, Hollmann MW, Stevens MF. Hermanns H, et al. Among authors: bos eme. CNS Drugs. 2022 Aug;36(8):877-896. doi: 10.1007/s40263-022-00936-y. Epub 2022 Jul 15. CNS Drugs. 2022. PMID: 35836037 Free PMC article. Review.

10

Increased microchimerism in peripheral blood of women with systemic lupus erythematosus: relation with pregnancy.

Bos EMJ, Rijnink EC, Zandbergen M, Diaz de Pool JDN, Almekinders MM, Berden JHM, Bijl M, Hagen EC, Kolster-Bijdevaate C, Steup-Beekman GM, Wolterbeek R, Bloemenkamp KWM, Baelde HJ, Bruijn JA, Bajema IM, Wilhelmus S. Bos EMJ, et al. Clin Exp Rheumatol. 2022 Apr 29. doi: 10.55563/clinexprheumatol/75tlgf. Online ahead of print. Clin Exp Rheumatol. 2022. PMID: 35579081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results